Neogen NEOG Stock
Neogen Price Chart
Neogen NEOG Financial and Trading Overview
| Neogen stock price | 11.47 USD |
| Previous Close | 11.3 USD |
| Open | 11.28 USD |
| Bid | 8.16 USD x 200 |
| Ask | 14.45 USD x 200 |
| Day's Range | 11.24 - 11.45 USD |
| 52 Week Range | 4.89 - 12.85 USD |
| Volume | 705.11K USD |
| Avg. Volume | 2.34M USD |
| Market Cap | 2.49B USD |
| Beta (5Y Monthly) | 1.77 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 13 USD |
NEOG Valuation Measures
| Enterprise Value | 3.09B USD |
| Trailing P/E | N/A |
| Forward P/E | 30 |
| PEG Ratio (5 yr expected) | 0.66 |
| Price/Sales (ttm) | 2.8559725 |
| Price/Book (mrq) | 1.1857706 |
| Enterprise Value/Revenue | 3.551 |
| Enterprise Value/EBITDA | 32.641 |
Trading Information
Neogen Stock Price History
| Beta (5Y Monthly) | 1.77 |
| 52-Week Change | 134.25% |
| S&P500 52-Week Change | 18.95% |
| 52 Week High | 12.85 USD |
| 52 Week Low | 4.89 USD |
| 50-Day Moving Average | 9.48 USD |
| 200-Day Moving Average | 8.7 USD |
NEOG Share Statistics
| Avg. Volume (3 month) | 2.34M USD |
| Avg. Daily Volume (10-Days) | 2.68M USD |
| Shares Outstanding | 218.06M |
| Float | 216.85M |
| Short Ratio | 5.43 |
| % Held by Insiders | 0.94% |
| % Held by Institutions | 114.07% |
| Shares Short | 10.79M |
| Short % of Float | 6.61% |
| Short % of Shares Outstanding | 4.95% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2026 |
| Most Recent Quarter (mrq) | May 31, 2026 |
| Next Fiscal Year End | May 31, 2027 |
Profitability
| Profit Margin | -0.90% |
| Operating Margin (ttm) | 1.37% |
| Gross Margin | 46.93% |
| EBITDA Margin | 10.87% |
Management Effectiveness
| Return on Assets (ttm) | -0.39% |
| Return on Equity (ttm) | -0.37% |
Income Statement
| Revenue (ttm) | 870.4M USD |
| Revenue Per Share (ttm) | 4 USD |
| Quarterly Revenue Growth (yoy) | -0.10% |
| Gross Profit (ttm) | 408.5M USD |
| EBITDA | 94.7M USD |
| Net Income Avi to Common (ttm) | -7900000 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 185.5M USD |
| Total Cash Per Share (mrq) | 0.85 USD |
| Total Debt (mrq) | 812.6M USD |
| Total Debt/Equity (mrq) | 38.83 USD |
| Current Ratio (mrq) | 3.822 |
| Book Value Per Share (mrq) | 9.614 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 83.2M USD |
| Levered Free Cash Flow (ttm) | 69.5M USD |
Profile of Neogen
| Country | United States |
| State | MI |
| City | Lansing |
| Address | 620 Lesher Place |
| ZIP | 48912-1595 |
| Phone | 517 372 9200 |
| Website | https://www.neogen.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 2636 |
Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.
Q&A For Neogen Stock
What is a current NEOG stock price?
Neogen NEOG stock price today per share is 11.47 USD.
How to purchase Neogen stock?
You can buy NEOG shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Neogen?
The stock symbol or ticker of Neogen is NEOG.
Which industry does the Neogen company belong to?
The Neogen industry is Medical Devices.
How many shares does Neogen have in circulation?
The max supply of Neogen shares is 213.4M.
What is Neogen Price to Earnings Ratio (PE Ratio)?
Neogen PE Ratio is now.
What was Neogen earnings per share over the trailing 12 months (TTM)?
Neogen EPS is -0.04 USD over the trailing 12 months.
Which sector does the Neogen company belong to?
The Neogen sector is Healthcare.
Neogen NEOG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26342.9 USD — |
-0.08
|
5.14B USD — | 26208.43 USD — | 26499.42 USD — | — - | 5.14B USD — |
US Tech Composite Total Return
XCMP
US
|
32499.16 USD — |
-0.08
|
— — | 32334.88 USD — | 32693.89 USD — | — - | — — |
US Tech US 700 Small Cap Value I
NQUS700SCV
US
|
2781.02 USD — |
-0.42
|
— — | 2779.17 USD — | 2801.8 USD — | — - | — — |
US Tech Global Select Market Com
NQGS
US
|
12934.63 USD — |
-0.07
|
— — | 12869.27 USD — | 13011.44 USD — | — - | — — |
US Tech Health Care
IXHC
US
|
1262.13 USD — |
-0.47
|
— — | 1260.6 USD — | 1279.07 USD — | — - | — — |
US Tech US 700 Small Cap Value N
NQUS700SCVN
US
|
3187.61 USD — |
-0.41
|
— — | 3185.48 USD — | 3211.43 USD — | — - | — — |
US Tech US 700 Small Cap Index
NQUS700SC
US
|
3211.51 USD — |
-0.74
|
— — | 3209.9 USD — | 3234.74 USD — | — - | — — |
- {{ link.label }} {{link}}


